Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/54325
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | Bartlewski, P. M. | |
dc.contributor.author | Aravindakshan, J. | |
dc.contributor.author | Beard, A. P. | |
dc.contributor.author | Nelson, M. L. | |
dc.contributor.author | Batista-Arteaga, M. | |
dc.contributor.author | Cook, S. J. | |
dc.contributor.author | Rawlings, N. C. | |
dc.date.accessioned | 2019-02-18T10:05:17Z | - |
dc.date.available | 2019-02-18T10:05:17Z | - |
dc.date.issued | 2004 | |
dc.identifier.issn | 0378-4320 | |
dc.identifier.uri | http://hdl.handle.net/10553/54325 | - |
dc.description.abstract | When ovulation is induced with gonadotrophin-releasing hormone (GnRH) in anoestrous ewes, a proportion of animals fail to form normal (full-lifespan) corpora lutea (CL). Progesterone treatment before GnRH prevents luteal inadequacy. It remains uncertain whether a similar effect, achieved with medroxyprogesterone acetate (MAP) from intravaginal sponges, is mediated by influences on growing ovarian follicles and/or secretion of gonadotrophic hormones, before and after GnRH treatment. Two experiments were performed, on 13 and 11 anoestrous Western white-faced ewes, respectively. Seven and six ewes, respectively, received MAP-containing sponges (60mg) for 14 days; the remaining ewes served as untreated controls. To test the effect of timing of GnRH administration after pre-treatment with MAP-releasing sponges, GnRH injections (250ng every 2h for 24h followed by a bolus injection of 125μg of GnRH i.v.) were given either immediately (Experiment 1) or 24h after sponge removal in the treated ewes (Experiment 2). Ovarian follicular dynamics (follicles reaching ≥5mm in size) and development of luteal structures were monitored using transrectal ultrasonography. In Experiment 1, the mean ovulation rate (0.7±0.3 and 1.0±0.4) and proportion of ovulating ewes (57 and 67%, respectively) did not vary (P>0.05) between MAP-treated and control ewes. Normal (full-lifespan) CL were detected in 29% of treated and 67% of control ewes (P>0.05). In Experiment 2, the mean ovulation rate (2.3±0.2 and 1.2±0.6; P<0.05) and percentage of ewes with normal (full-lifespan) CL (100 and 40%, respectively; P<0.10) were greater in the treated compared to control ewes. In Experiment 1, the mean peak concentration of the GnRH-induced LH surge was lower (P<0.05) in MAP-treated than in control ewes. There were no significant differences between MAP-treated and control ewes in the characteristics of follicular waves, mean daily serum FSH concentrations, and secretory parameters of LH/FSH, based on intensive blood sampling conducted 1 day before sponging and 1 day before sponge removal. It is concluded that treatment with MAP has no effect on the tonic secretion of LH/FSH or follicular wave development in anoestrous ewes. However, the GnRH-stimulated LH discharge was attenuated in the ewes that received MAP-impregnated sponges for 14 days and were treated with GnRH immediately after sponge withdrawal. Ovulatory response and CL formation were increased when GnRH was administered 24h after sponge removal. © 2003 Elsevier B.V. All rights reserved. | |
dc.publisher | 0378-4320 | |
dc.relation.ispartof | Animal Reproduction Science | |
dc.source | Animal Reproduction Science[ISSN 0378-4320],v. 81, p. 63-75 | |
dc.title | Effects of medroxyprogesterone acetate (MAP) on ovarian antral follicle development, gonadotrophin secretion and response to ovulation induction with gonadotrophin-releasing hormone (GnRH) in seasonally anoestrous ewes | |
dc.type | info:eu-repo/semantics/Article | |
dc.type | Article | |
dc.identifier.doi | 10.1016/j.anireprosci.2003.10.002 | |
dc.identifier.scopus | 1142265911 | |
dc.contributor.authorscopusid | 6701851423 | |
dc.contributor.authorscopusid | 6507505319 | |
dc.contributor.authorscopusid | 7004524599 | |
dc.contributor.authorscopusid | 57198484703 | |
dc.contributor.authorscopusid | 6506315360 | |
dc.contributor.authorscopusid | 8975211100 | |
dc.contributor.authorscopusid | 7005301556 | |
dc.description.lastpage | 75 | |
dc.description.firstpage | 63 | |
dc.relation.volume | 81 | |
dc.type2 | Artículo | |
dc.date.coverdate | Enero 2004 | |
dc.identifier.ulpgc | Sí | es |
dc.description.jcr | 1,41 | |
dc.description.jcrq | Q1 | |
dc.description.scie | SCIE | |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Medicina Veterinaria e Investigación Terapéutica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Patología Animal, Producción Animal, Bromatología y Tecnología de Los Alimentos | - |
crisitem.author.orcid | 0000-0001-9753-4786 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Batista Arteaga, Miguel | - |
Colección: | Artículos |
Citas SCOPUSTM
18
actualizado el 17-nov-2024
Citas de WEB OF SCIENCETM
Citations
16
actualizado el 17-nov-2024
Visitas
102
actualizado el 13-sep-2024
Google ScholarTM
Verifica
Altmetric
Comparte
Exporta metadatos
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.